Exelixis Inc (EXEL US)

Analysis

Health Care • United States

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.

Refresh

Company Event • 04 Nov 2026 06:00 • Upcoming

Add To Calendar

Q3 2026

Company Event • 15 Sep 2026 23:30 • Latest

Morgan Stanley 24th Annual Global Healthcare Conference

Company Event • 09 Sep 2026 20:40

Citigroup’s Biopharma Back to School Summit 2026

Company Event • 08 Sep 2026 23:00

Wells Fargo 21st Annual Healthcare Conference

Company Event • 06 Aug 2026 05:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q3 2026

Morgan Stanley 24th Annual Global Healthcare Conference

Citigroup’s Biopharma Back to School Summit 2026

Wells Fargo 21st Annual Healthcare Conference

Q2 2026